Oncorus, Inc.
ONCR
ONCR was delisted on the 20th of June, 2023.
40 hedge funds and large institutions have $14.1M invested in Oncorus, Inc. in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 45 → 40 (-5)
34% less capital invested
Capital invested by funds: $21.4M → $14.1M (-$7.36M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$29.5K |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$17.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.66K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.16K |
| 5 |
JP Morgan Chase
New York
|
+$398 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$120K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$103K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$72.2K |
| 4 |
Two Sigma Advisers
New York
|
-$54.6K |
| 5 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$52.1K |
ONCR Hedge Fund Activity: Q3 2022 in Review
40 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Oncorus, Inc. (ONCR) for Q3 2022, worth a combined $14.1M — down 34% from $21.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ONCR and 3 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, adding an estimated $29.5K. The largest seller was Goldman Sachs, cutting an estimated $120K.
- 40 institutional investors held Oncorus, Inc. (ONCR) as of Q3 2022, down from 45 in Q2 2022.
- Funds reported $14.1M of Oncorus, Inc. stock for Q3 2022, down 34% quarter-over-quarter.
- 3 funds opened new Oncorus, Inc. positions in Q3 2022 and 8 closed out, a net change of -5 holders.
- The largest Oncorus, Inc. buyer in Q3 2022 was Citadel Advisors, an estimated $29.5K added.
- The largest Oncorus, Inc. seller in Q3 2022 was Goldman Sachs, an estimated $120K sold.
Based on aggregated 13F filings for Q3 2022.